Pliant Therapeutics (PLRX) Return on Assets (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Return on Assets for 6 consecutive years, with 0.59% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 9.0% to 0.59% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.59% through Dec 2025, down 9.0% year-over-year, with the annual reading at 0.47% for FY2025, 1.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.59% at Pliant Therapeutics, up from 0.61% in the prior quarter.
  • The five-year high for Return on Assets was 0.25% in Q2 2023, with the low at 0.64% in Q2 2025.
  • Average Return on Assets over 5 years is 0.42%, with a median of 0.39% recorded in 2021.
  • The sharpest move saw Return on Assets crashed -44bps in 2021, then skyrocketed 33bps in 2023.
  • Over 5 years, Return on Assets stood at 0.43% in 2021, then rose by 21bps to 0.34% in 2022, then increased by 10bps to 0.31% in 2023, then tumbled by -63bps to 0.5% in 2024, then fell by -18bps to 0.59% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.59%, 0.61%, and 0.64% for Q4 2025, Q3 2025, and Q2 2025 respectively.